1. Home
  2. INTS vs CVR Comparison

INTS vs CVR Comparison

Compare INTS & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • CVR
  • Stock Information
  • Founded
  • INTS 2012
  • CVR 1920
  • Country
  • INTS United States
  • CVR United States
  • Employees
  • INTS N/A
  • CVR N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • CVR Industrial Machinery/Components
  • Sector
  • INTS Health Care
  • CVR Industrials
  • Exchange
  • INTS Nasdaq
  • CVR Nasdaq
  • Market Cap
  • INTS 12.2M
  • CVR 9.8M
  • IPO Year
  • INTS 2023
  • CVR N/A
  • Fundamental
  • Price
  • INTS $0.31
  • CVR $9.76
  • Analyst Decision
  • INTS Strong Buy
  • CVR
  • Analyst Count
  • INTS 4
  • CVR 0
  • Target Price
  • INTS $4.50
  • CVR N/A
  • AVG Volume (30 Days)
  • INTS 5.0M
  • CVR 2.8K
  • Earning Date
  • INTS 11-12-2025
  • CVR 11-11-2025
  • Dividend Yield
  • INTS N/A
  • CVR 1.23%
  • EPS Growth
  • INTS N/A
  • CVR N/A
  • EPS
  • INTS N/A
  • CVR N/A
  • Revenue
  • INTS N/A
  • CVR $25,617,681.00
  • Revenue This Year
  • INTS N/A
  • CVR N/A
  • Revenue Next Year
  • INTS N/A
  • CVR N/A
  • P/E Ratio
  • INTS N/A
  • CVR N/A
  • Revenue Growth
  • INTS N/A
  • CVR N/A
  • 52 Week Low
  • INTS $0.19
  • CVR $8.15
  • 52 Week High
  • INTS $3.75
  • CVR $22.27
  • Technical
  • Relative Strength Index (RSI)
  • INTS 64.31
  • CVR 41.14
  • Support Level
  • INTS $0.27
  • CVR $9.52
  • Resistance Level
  • INTS $0.30
  • CVR $11.08
  • Average True Range (ATR)
  • INTS 0.03
  • CVR 0.55
  • MACD
  • INTS 0.01
  • CVR 0.02
  • Stochastic Oscillator
  • INTS 60.25
  • CVR 36.23

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

Share on Social Networks: